⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene SCHEMBL10012395 | 0.93 | — | — | |
| SCHEMBL2486860 | 0.80 | FDPS (0.44) | — | |
| SCHEMBL88353 | 0.78 | — | — | |
| SCHEMBL27863157 | 0.78 | FDPS (0.50) | — | |
| SCHEMBL565215 | 0.75 | — | — | |
| SCHEMBL5932144 | 0.75 | — | — | |
| SCHEMBL18109925 | 0.75 | — | — | |
| SCHEMBL1516447 | 0.75 | — | — | |
| SCHEMBL93748 | 0.75 | — | — | |
| SCHEMBL15136237 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5861513-A | Preparation of 1-acetyl-4-piperidones | BASF AKTIENGESELLSCHAFT (DE) | 1999-01-19 | — | — | US | claimed |
| US-20150057220-A1 | FUSED AROMATIC PHOSPHONATE DERIVATIVES AS PRECURSORS TO PTP-1B INHIBITORS | MERCK CANADA INC. (CA) | 2015-02-26 | — | — | US | disclosed |
| EP-2838906-A1 | FUSED AROMATIC PHOSPHONATE DERIVATIVES AS PRECURSORS TO PTP-1B INHIBITORS | Kaneq Pharma Inc. (CA) | 2015-02-25 | — | — | EP | disclosed |
| WO-2013155600-A1 | FUSED AROMATIC PHOSPHONATE DERIVATIVES AS PRECURSORS TO PTP-1B INHIBITORS | KANEQ PHARMA (CA) | 2013-10-24 | — | — | WO | disclosed |
| EP-2611731-A1 | MANUFACTURE OF LIPO2F2 FROM POF3 OR PF5 | SOLVAY SA (BE) | 2013-07-10 | — | — | EP | disclosed |
| WO-2012016924-A1 | MANUFACTURE OF LIPO2F2 FROM POF3 OR PF5 | SOLVAY SA (BE) | 2012-02-09 | — | — | WO | disclosed |
| EP-1755574-A4 | PTEN INHIBITORS | SEMAFORE PHARMACEUTICALS INC (US) | 2009-05-13 | — | — | EP | disclosed |
| US-20070203098-A1 | Pten Inhibitors | SEMAFORE PHARMACEUTICALS, INC. (US) | 2007-08-30 | — | — | US | disclosed |
| EP-1755574-A2 | PTEN INHIBITORS | Semafore Pharmaceuticals, Inc. (US) | 2007-02-28 | — | — | EP | disclosed |
| WO-2005097119-A2 | PTEN INHIBITORS | SEMAFORE PHARMACEUTICALS, INC. (US) | 2005-10-20 | — | — | WO | disclosed |
| EP-1019418-A1 | A NEW CHEMICAL COMPOUND | PERSTORP AB (SE) | 2000-07-19 | — | — | EP | disclosed |
| WO-1997026266-A1 | A NEW CHEMICAL COMPOUND | PERSTORP AB (SE) | 1997-07-24 | — | — | WO | disclosed |
| US-5475129-A | Phosphonoalkyl phenylalanine compounds suitably protected for use in peptide synthesis | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-12-12 | — | — | US | disclosed |
| WO-1993025561-A1 | PHOSPHONOALKYL PHENYLALANINE COMPOUNDS SUITABLY PROTECTED FOR USE IN PEPTIDE SYNTHESIS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1993-12-23 | — | — | WO | disclosed |
| US-5264607-A | Process of making benzylic α,α-diflurophosphonates from benzylic α-ketophosphorates | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1993-11-23 | — | — | US | disclosed |